technetium-tc-99m-sulfur-colloid and Breast-Cancer-Lymphedema

We evaluated the prognostic value of lymphoscintigraphy after complex decongestive therapy (CDT) in breast cancer-related secondary lymphedema.. Prior to CDT, 80 patients with breast cancer-related lymphedema underwent a. There were 50 poor responders and 30 responders 1 year after CDT. There were significant differences between the two groups with regard to compliance (P < 0.05) and visualization of axillary LNs (P < 0.05). In combined results, the odds ratio was 21.33 (2.37-192.03) in the compliance and visible axillary LNs group compared to the poor compliance and invisible axillary LNs group.. Lymphoscintigraphy of the upper extremities can be a useful tool to predict the prognosis of CDT in breast cancer-related lymphedema patients.

Topics: Adult; Aged; Breast Cancer Lymphedema; Combined Modality Therapy; Female; Humans; Lymphoscintigraphy; Middle Aged; Neoplasm Staging; Odds Ratio; Prognosis; Technetium Tc 99m Sulfur Colloid; Treatment Outcome